Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Ndashimye

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen FailureFred Kyeyune, Richard M Gibson, Immaculate Nankya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
Infectious Diseases of Poverty|December 6, 2017
Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countriesRichard M Gibson, Gabrielle Nickel, Michael Crawford, et al.
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2020
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Abayomi S Olabode, et al.
Plos Medicine|November 15, 2017
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trialAlexander J Szubert, Andrew J Prendergast, Moira J Spyer, et al.
Plos Pathogens|January 19, 2018
Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infectionKatja Klein, Gabrielle Nickel, Immaculate Nankya, et al.
Antibodies (Basel, Switzerland)|April 23, 2025
Discovery of Antibodies Against Endemic Coronaviruses with NGS-Based Human Fab Phage Display PlatformOscar Chi-Chien Pan, Sean Miller, Ruchin Patel, et al.
Emerging Microbes & Infections|March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infectionMinh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen FailureFred Kyeyune, Richard M Gibson, Immaculate Nankya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
Infectious Diseases of Poverty|December 6, 2017
Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countriesRichard M Gibson, Gabrielle Nickel, Michael Crawford, et al.
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2020
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Abayomi S Olabode, et al.
Plos Medicine|November 15, 2017
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trialAlexander J Szubert, Andrew J Prendergast, Moira J Spyer, et al.
Plos Pathogens|January 19, 2018
Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infectionKatja Klein, Gabrielle Nickel, Immaculate Nankya, et al.
Antibodies (Basel, Switzerland)|April 23, 2025
Discovery of Antibodies Against Endemic Coronaviruses with NGS-Based Human Fab Phage Display PlatformOscar Chi-Chien Pan, Sean Miller, Ruchin Patel, et al.
Emerging Microbes & Infections|March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infectionMinh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Pageof 2